Aminalon is a substance with nootropic and psychostimulatory qualities. Gamma-Aminobutyric acid is the only active component in this drug. Aminalon (C4H9NO2) is a neurotransmitter which slows nerve impulse. Gamma-Aminobutyric acid (also known as GABA, γ-aminobutyric acid) is synthesised in the brain from glutamic acid (another neurotransmitter) through decarboxylation (a chemical reaction that removes a carboxyl group and releases carbon dioxide).

Researchers discovered Gamma-Aminobutyric acid in 1950. It was marketed in Japan in the 1960’s under the name Gammalon. The drug then appeared in the USSR in the 1970’s as Aminalon.

The main property of GABA is that it regulates blood flow in the brain, improves memory, speech, and coordination. It increases oxygen levels in nerve tissue and protects against convulsions. GABA facilitates absorption of glucose. It can also lower blood pressure, regulate sleep, and remove toxic metabolites.

Indications for use:

  • Atherosclerosis of cerebral arteries accompanied by mental deterioration;
  • Arterial hypertension;
  • Symptoms from head and brain trauma and circulatory problems in the brain;
  • Cerebral blood vessel disease, especially when accompanied by head pain and vertigo;
  • Memory, speech, and attention problems as a result of chronic cerebrovascular illness;
  • Alcoholic polyneuropathy and encephalopathy;
  • Seasickness.
  • Aminalon is indicated for children for:

  • Treatment of birth and brain trauma;
  • Intellectual disability and developmental delay;
  • Children’s cerebral palsy;
  • Seasickness.
  • As mentioned above, the active component of Aminalon is Gamma-Aminobutyric acid (GABA). It facilitates cerebral metabolic processes. It works thanks to the interaction between its active element and specific receptors in the brain. As a result, blood flow to the brain normalises, as well as cellular respiration and energy production. GABA works to remove toxic substances and harmful metabolic products while regulating the body’s use of glucose. This leads to an overall regulation of CNS processes. The patient experiences improved memory and thinking as well as recovery of speech and motor skills lost due to reduced blood flow to the brain. Additionally, the active component of the drug stabilises arterial pressure, alleviating unpleasant symptoms such as interrupted sleep, vertigo, and convulsions. Patients suffering from diabetes notice lowered blood sugar after taking the drug.